These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 9070935
1. Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively. Mattei MG, Roeckel N, Olsen BR, Apte SS. Genomics; 1997 Feb 15; 40(1):168-9. PubMed ID: 9070935 [Abstract] [Full Text] [Related]
2. Assignment of the human genes for membrane-type-1, -2, and -3 matrix metalloproteinases (MMP14, MMP15, and MMP16) to 14q12.2, 16q12.2-q21, and 8q21, respectively, by in situ hybridization. Sato H, Tanaka M, Takino T, Inoue M, Seiki M. Genomics; 1997 Feb 01; 39(3):412-3. PubMed ID: 9119382 [No Abstract] [Full Text] [Related]
3. Mapping of two mouse membrane-type matrix metalloproteinase (MT-MMP) genes, Mmp15 and Mmp16, to mouse chromosomes 8 and 4, respectively. Seldin MF, Gustavson MD, Apte SS. Genomics; 1998 Jun 01; 50(2):295-7. PubMed ID: 9653660 [No Abstract] [Full Text] [Related]
4. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland. Szabova L, Yamada SS, Birkedal-Hansen H, Holmbeck K. J Cell Physiol; 2005 Oct 01; 205(1):123-32. PubMed ID: 15895410 [Abstract] [Full Text] [Related]
5. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells. Ohnishi Y, Tajima S, Ishibashi A. Eur J Dermatol; 2001 Oct 01; 11(5):420-3. PubMed ID: 11525948 [Abstract] [Full Text] [Related]
6. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y. Cancer Res; 1999 Jan 15; 59(2):467-73. PubMed ID: 9927064 [Abstract] [Full Text] [Related]
7. Assignment of the human membrane-type matrix metalloproteinase (MMP14) gene to 14q11-q12 by in situ hybridization. Mignon C, Okada A, Mattei MG, Basset P. Genomics; 1995 Jul 20; 28(2):360-1. PubMed ID: 8530054 [No Abstract] [Full Text] [Related]
8. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Sato H, Okada Y, Seiki M. Thromb Haemost; 1997 Jul 20; 78(1):497-500. PubMed ID: 9198203 [Abstract] [Full Text] [Related]
9. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice. Drew AF, Blick TJ, Lafleur MA, Tim EL, Robbie MJ, Rice GE, Quinn MA, Thompson EW. Gynecol Oncol; 2004 Dec 20; 95(3):437-48. PubMed ID: 15581944 [Abstract] [Full Text] [Related]
10. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Gilles C, Polette M, Seiki M, Birembaut P, Thompson EW. Lab Invest; 1997 May 20; 76(5):651-60. PubMed ID: 9166284 [Abstract] [Full Text] [Related]
11. Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester. Bjørn SF, Hastrup N, Larsen JF, Lund LR, Pyke C. Placenta; 2000 May 20; 21(2-3):170-6. PubMed ID: 10736239 [Abstract] [Full Text] [Related]
12. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H. Hum Pathol; 2000 Aug 20; 31(8):895-904. PubMed ID: 10987249 [Abstract] [Full Text] [Related]
14. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. Shofuda K, Nagashima Y, Kawahara K, Yasumitsu H, Miki K, Miyazaki K. Lab Invest; 1998 Aug 20; 78(8):915-23. PubMed ID: 9714179 [Abstract] [Full Text] [Related]
15. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y, Yeon J, Kim HJ, Lee ST. Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [Abstract] [Full Text] [Related]
16. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y. Cancer Res; 1997 May 15; 57(10):2055-60. PubMed ID: 9158005 [Abstract] [Full Text] [Related]
17. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue. Jung M, Römer A, Keyszer G, Lein M, Kristiansen G, Schnorr D, Loening SA, Jung K. Prostate; 2003 May 01; 55(2):89-98. PubMed ID: 12661033 [Abstract] [Full Text] [Related]
18. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. Tyagi SC, Lewis K, Pikes D, Marcello A, Mujumdar VS, Smiley LM, Moore CK. J Cell Physiol; 1998 Aug 01; 176(2):374-82. PubMed ID: 9648925 [Abstract] [Full Text] [Related]
19. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Nakada M, Miyamori H, Yamashita J, Sato H. Cancer Res; 2003 Jun 15; 63(12):3364-9. PubMed ID: 12810672 [Abstract] [Full Text] [Related]
20. Localization of the human membrane-type 2 matrix metalloproteinase gene (MMP15) to 16q12.1 near DNA elements that are part of centromeric and non-centromeric heterochromatin of 11 human chromosomes. Koehler MR, Sauer CG, Reismann N, Steinlein C, Weber BH, Will H, Schmid M. Chromosome Res; 1998 Apr 15; 6(3):199-203. PubMed ID: 9609663 [Abstract] [Full Text] [Related] Page: [Next] [New Search]